±Ù°Å Áß½ÉÀÇ Àü¸³¼±ºñ´ëÁõ Ä¡·á¸¦ ÁöÇâ
Àü¸³¼±ºñ´ëÁõ, ¹è´¢Àå¾Ö, ¿©¼º ¿ä½Ç±Ý, °ú¹Î¼º¹æ±¤À» Áø·áÇÑ´Ù. ȯÀÚÀÇ Áõ»ó¿¡ µû¸¥ ±Ù°Å Áß½ÉÀÇ Ä¡·á¸¦ ÁöÇâÇÏ´Â À±º´ÀÏ ±³¼ö´Â dzºÎÇÑ ÀÓ»ó °æÇèÀ» °®°í ÀÖ´Ù. ¶ÇÇÑ ´ëÇѳ²¼º°úÇÐȸ ÃÖ¿ì¼ö ³í¹®»ó, ÃÖ´Ù³í¹®»óÀ» ¼ö»óÇÒ Á¤µµ·Î Ȱ¹ßÇÑ Çмú Ȱµ¿À» ¼öÇàÇß´Ù. ÇöÀç´Â °¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø ºñ´¢ÀÇÇаú °úÀåÀ» ¸Ã°í ÀÖÀ¸¸ç, °æÀÎÁö¿ª ºñ´¢ÀÇÇаúÀÇ»çȸ ÀÌ»ç·Îµµ Ȱµ¿ ÁßÀÌ´Ù.
| Á¦ ¸ñ | Optimal dual-energy computed tomography scan parameters to detect small-sized urinary stones and their composition | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | Urolithiasis |
| Á¦ ¸ñ | Impact of age and metabolic syndrome-like components on prostate cancer developement: a nationwide population-based cohort study | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | Translational andrology and urology |
| Á¦ ¸ñ | How Much Reliable Is the Current Belief on Grade Group 1 Prostate Cancer? | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | Pathol Oncol Res |
| Á¦ ¸ñ | Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | World J Mens Health |
| Á¦ ¸ñ | Association between the neutrophil-to-lymphocyte ratio and intravesical prostatic protrusion in men with benign prostatic hyperplasia | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2019 | ¹ßÇ¥Áö | Lower urinary tract symptoms |
| Á¦ ¸ñ | Suppression of Oxidative Stress of Modified Gongjin-Dan (WSY-1075) in Detrusor Underactivity Rat Model Bladder Outlet Induced by Obstruction. | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2018 | ¹ßÇ¥Áö | CHINESE JOURNAL OF INTEGRATIVE MEDICINE |
| Á¦ ¸ñ | Anti-inflammatory and Antimicrobial Effects of Anthocyanin Extracted from Black Soybean on Chronic Bacterial Prostatitis Rat Model | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2018 | ¹ßÇ¥Áö | CHINESE JOURNAL OF INTEGRATIVE MEDICINE |

°¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿øÀº °¡Å縯±³È¸ Á¤½ÅÀÎ ±×¸®½ºµµÀÇ ÀǼú·Î ÀηùÀÇ ¾ÆÇ ¸ö°ú ¸¶À½À» Ä¡À¯ÇÑ´Ù´Â ¹Ì¼Ç ¾Æ·¡ ¼³¸³µÆ´Ù. ÀÎõ±¹Á¦°øÇ×°ú °¡Àå °¡±î¿î ´ëÇѹα¹ÀÇ °ü¹® º´¿øÀÌÀÚ, ÀÎõ ¼±¸¿Í ¿µÁ¾µµ, °È, ±èÆ÷ Áö¿ª ÃÖÃÊ-À¯ÀÏÀÇ ´ëÇк´¿øÀÌ´Ù. ½ÉÀåÇ÷°ü¼¾ÅÍ, ·Îº¿¼ö¼ú¼¾ÅÍ, °ÅÁ¡Áö¿ª ÀÀ±ÞÀÇ·á¼¾ÅÍ, ±¹Á¦Áø·á¼¾ÅÍ µî Àü¹® ¼¾Å͸¦ ¿î¿µÇϸç ÁßÁõÀÀ±ÞÁúȯ Ä¡·á¿¡ Èû¾²°í ÀÖ´Ù.
ÀÎõ±¤¿ª½Ã ¼±¸ ½É°î·Î 100¹ø±æ 25